نتائج البحث

Cost Effectiveness of F-18-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy

• Authors : Rosen, Jurij; Ceccon, Garry; Bauer, Elena K.

Subjects: ddc:no; doc-type:article; status-type:publishedVersion

تفاصيل العنوان

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma

• Authors : Vieito, Maria; Simonelli, Matteo; De Vos, Filip

Subjects: article

• Source: Vieito , M , Simonelli , M , De Vos , F , Moreno , V , Geurts , M , Lorenzi , E , Macchini , M , Van Den Bent , M J , Del Conte , G , De Jonge , M , Martín-Soberón , M C , Amoroso , B ,

تفاصيل العنوان

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma

• Authors : MS Medische Oncologie; Cancer; Vieito, Maria

تفاصيل العنوان

Early Treatment Response Assessment Using F-18-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy

• Authors : Ceccon, Garry; Lohmann, Philipp; Werner, Jan-Michael

Subjects: ddc:no; doc-type:article; publishedVersion

تفاصيل العنوان

Early Treatment Response Assessment Using F-18-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy

• Authors : Ceccon, Garry; Lohmann, Philipp; Werner, Jan-Michael

Subjects: ddc:no; doc-type:article; status-type:publishedVersion

تفاصيل العنوان

Prognostic value of pretreatment systemic immune-inflammation index in glioblastoma multiforme patients undergoing postneurosurgical radiotherapy plus concurrent and adjuvant temozolomide

• Authors : Selek, Uğur (ORCID 0000-0001-8087-3140 & YÖK ID 27211); Topkan, Erkan; Besen, Ali A.

Subjects: Medicine; Tumor; text/academic publication

• Source: Mediators of Inflammation

تفاصيل العنوان

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.

• Authors : UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie; UCL - (SLuc) Unité d'oncologie médicale; UCL - (SLuc) Centre du cancer

Subjects: info:eu-repo/semantics/article

• Source: The Lancet, Vol. 390, no.10103, p. 1645-1653 (2017)

تفاصيل العنوان

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

• Authors : Bent, M.J. van den; Baumert, B.; Erridge, S.C.

• Source: The Lancet (London); 1645; 1653; 0140-6736; 10103; 390; ~The Lancet (London)~1645~1653~~~0140-6736~10103~390~~

تفاصيل العنوان

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

• Authors : Bent, M.J. van den; Baumert, B.; Erridge, S.C.

• Source: The Lancet (London); 1645; 1653; 0140-6736; 10103; 390; ~The Lancet (London)~1645~1653~~~0140-6736~10103~390~~

تفاصيل العنوان

Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.

• Authors : Nayak, Lakshmi; Nayak, Lakshmi; de Groot, John

Subjects: Humans; Glioma; Brain Neoplasms

• Source: Journal of neuro-oncology; vol 132, iss 1, 181-188; 0167-594X

تفاصيل العنوان